Akimoto T - Search Results

1

Febuxostat for hyperuricemia in patients with advanced chronic kidney disease.

Akimoto T, Morishita Y, Ito C, Iimura O, Tsunematsu S, Watanabe Y, Kusano E, Nagata D. Akimoto T, et al. Drug Target Insights. 2014 Aug 13;8:39-43. doi: 10.4137/DTI.S16524. eCollection 2014. Drug Target Insights. 2014. PMID: 25210423 Free PMC article.

2

AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells.

Umino T, Kusano E, Muto S, Akimoto T, Yanagiba S, Ono S, Amemiya M, Ando Y, Homma S, Ikeda U, Shimada K, Asano Y. Umino T, et al. Among authors: akimoto t. Am J Physiol. 1999 Mar;276(3):F433-41. doi: 10.1152/ajprenal.1999.276.3.F433. Am J Physiol. 1999. PMID: 10070167

3

Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells.

Kusano E, Akimoto T, Inoue M, Masunaga Y, Umino T, Ono S, Ando Y, Homma S, Muto S, Komatsu N, Asano Y. Kusano E, et al. Among authors: akimoto t. Nephrol Dial Transplant. 1999 Mar;14(3):597-603. doi: 10.1093/ndt/14.3.597. Nephrol Dial Transplant. 1999. PMID: 10193805

4

[Factors related to the QT prolongation in chronic renal failure].

Kurosu M, Ando Y, Akimoto T, Ono S, Kusano E, Asano Y. Kurosu M, et al. Among authors: akimoto t. Nihon Jinzo Gakkai Shi. 1999 Apr;41(2):70-6. Nihon Jinzo Gakkai Shi. 1999. PMID: 10361422 Japanese.

5

The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells.

Akimoto T, Kusano E, Muto S, Fujita N, Okada K, Saito T, Komatsu N, Ono S, Ebata S, Ando Y, Homma S, Asano Y. Akimoto T, et al. J Hypertens. 1999 Sep;17(9):1249-56. doi: 10.1097/00004872-199917090-00003. J Hypertens. 1999. PMID: 10489101

6

Effect of plasmapheresis as initial monotherapy in a case of anti-neutrophil cytoplasmic autoantibody positive crescentic glomerulonephritis.

Akimoto T, Ando Y, Ito C, Muto S, Kusano E, Asano Y. Akimoto T, et al. ASAIO J. 1999 Sep-Oct;45(5):509-13. doi: 10.1097/00002480-199909000-00026. ASAIO J. 1999. PMID: 10503634

7

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway.

Akimoto T, Kusano E, Inaba T, Iimura O, Takahashi H, Ikeda H, Ito C, Ando Y, Ozawa K, Asano Y. Akimoto T, et al. Kidney Int. 2000 Jul;58(1):269-82. doi: 10.1046/j.1523-1755.2000.00162.x. Kidney Int. 2000. PMID: 10886572 Free article.

8

[Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].

Ito C, Ando Y, Akimoto T, Kusano E, Asano Y. Ito C, et al. Among authors: akimoto t. Nihon Jinzo Gakkai Shi. 2000 Jul;42(5):374-80. Nihon Jinzo Gakkai Shi. 2000. PMID: 10998918 Japanese.

9

Involvement of erythropoietin-induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells.

Akimoto T, Kusano E, Ito C, Yanagiba S, Inoue M, Amemiya M, Ando Y, Asano Y. Akimoto T, et al. J Hypertens. 2001 Feb;19(2):193-202. doi: 10.1097/00004872-200102000-00005. J Hypertens. 2001. PMID: 11212961

10

Erythropoietin modulates angiotensin II- or noradrenaline-induced Ca(2+) mobilization in cultured rat vascular smooth-muscle cells.

Akimoto T, Kusano E, Fujita N, Okada K, Saito O, Ono S, Ando Y, Homma S, Saito T, Asano Y. Akimoto T, et al. Nephrol Dial Transplant. 2001 Mar;16(3):491-9. doi: 10.1093/ndt/16.3.491. Nephrol Dial Transplant. 2001. PMID: 11239021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,195 results

Search Page

Filters